152 related articles for article (PubMed ID: 3907346)
1. Use of the saline infusion test to diagnose the cause of primary aldosteronism.
Arteaga E; Klein R; Biglieri EG
Am J Med; 1985 Dec; 79(6):722-8. PubMed ID: 3907346
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
Brown RD; Kem DC; Hogan MJ; Hegstad RL
Metabolism; 1984 Aug; 33(8):734-8. PubMed ID: 6748946
[TBL] [Abstract][Full Text] [Related]
3. A new diagnostic test for primary aldosteronism.
Coruzzi P; Musiari L; Biggi A; Carra N; Panzali AF; Novarini A
Am J Hypertens; 1991 Aug; 4(8):694-9. PubMed ID: 1930852
[TBL] [Abstract][Full Text] [Related]
4. Single dose captopril as a diagnostic test for primary aldosteronism.
Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML
J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726
[TBL] [Abstract][Full Text] [Related]
5. Activation of aldosterone secretion in primary aldosteronism.
Spark RF; Dale SL; Kahn PC; Melby JC
J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
[TBL] [Abstract][Full Text] [Related]
6. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
Biglieri EG; Schambelan M
J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820
[TBL] [Abstract][Full Text] [Related]
7. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
Irony I; Kater CE; Biglieri EG; Shackleton CH
Am J Hypertens; 1990 Jul; 3(7):576-82. PubMed ID: 2194512
[TBL] [Abstract][Full Text] [Related]
8. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
Nakada T
Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
[TBL] [Abstract][Full Text] [Related]
9. [Macronodule associated with bilateral adrenal hyperplasia. A rare misleading cause of primary aldosteronism (two cases)].
Leprat F; Tabarin A; Dubourg H; Barat JL; Ducassou D; Roger P; Dallocchio M; Latapie JL
Presse Med; 1991 May; 20(19):899-902. PubMed ID: 1829188
[TBL] [Abstract][Full Text] [Related]
10. [Does the captopril test improve the diagnosis of primary hyperaldosteronism?].
Wambach G; Degenhardt S; Bönner G; Stimpel M; Grimm U; Krone W
Dtsch Med Wochenschr; 1992 Jul; 117(31-32):1175-80. PubMed ID: 1644014
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
[TBL] [Abstract][Full Text] [Related]
12. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
13. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Witzgall H; Lorenz R; von Werder K; Weber PC
Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
[TBL] [Abstract][Full Text] [Related]
14. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
Ganguly A; Luetscher JA; Weinberger MH
Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
[TBL] [Abstract][Full Text] [Related]
15. [Primary aldosteronism: diagnosis, laterality and regulation of hormone secretion].
Vetter H; Vetter W; Beckerhoff R; Sobbe A; Nussberger J; Witassek F; Siegenthaler W
Schweiz Med Wochenschr; 1975 Dec; 105(50):1695-8. PubMed ID: 1215958
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
Takeda Y; Miyamori I; Iki K; Takeda R; Vecsei P
Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080
[TBL] [Abstract][Full Text] [Related]
17. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels.
Kem DC; Tang K; Hanson CS; Brown RD; Painton R; Weinberger MH; Hollifield JW
J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794
[TBL] [Abstract][Full Text] [Related]
18. The diagnosis of primary hyperaldosteronism.
Vaughan NJ; Jowett TP; Slater JD; Wiggins RC; Lightman SL; Ma JT; Payne NN
Lancet; 1981 Jan; 1(8212):120-5. PubMed ID: 6109800
[TBL] [Abstract][Full Text] [Related]
19. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
